{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:28:31Z","timestamp":1776893311973,"version":"3.51.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10620-020-06544-4","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T06:02:52Z","timestamp":1597903372000},"page":"739-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perceived Barriers to Treatment in Persons Treated for Functional Gastrointestinal Disease with Constipation"],"prefix":"10.1007","volume":"66","author":[{"given":"Klaus","family":"Bielefeldt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"6544_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/ajg.2011.164","volume":"106","author":"NC Suares","year":"2011","unstructured":"Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582\u20131591.","journal-title":"Am J Gastroenterol"},{"key":"6544_CR2","doi-asserted-by":"crossref","unstructured":"Whitehead WE, Crowell MD, Bosmajian L, et al. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples. Gastroenterology. 1990;98:336\u2013340.","DOI":"10.1016\/0016-5085(90)90822-I"},{"key":"6544_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/13696998.2016.1253584","volume":"20","author":"LM Herrick","year":"2017","unstructured":"Herrick LM, Spalding WM, Saito YA, et al. A case\u2013control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort. J Med Econ. 2017;20:273\u2013279.","journal-title":"J Med Econ"},{"key":"6544_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12876-019-0985-1","volume":"19","author":"J Tack","year":"2019","unstructured":"Tack J, Stanghellini V, Mearin F, et al. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries. BMC Gastroenterol. 2019;19:69.","journal-title":"BMC Gastroenterol"},{"key":"6544_CR5","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1185\/03007995.2011.623157","volume":"27","author":"M DiBonaventura","year":"2011","unstructured":"DiBonaventura M, Sun SX, Bolge SC, et al. Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome. Curr Med Res Opin. 2011;27:2213\u20132222.","journal-title":"Curr Med Res Opin"},{"key":"6544_CR6","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.cgh.2019.08.016","volume":"17","author":"S Ballou","year":"2019","unstructured":"Ballou S, McMahon C, Lee HN, et al. Effects of irritable bowel syndrome on daily activities vary among subtypes based on results from the IBS in America Survey. Clin Gastroenterol Hepatol. 2019;17:2471\u20132478.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6544_CR7","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.cgh.2019.02.039","volume":"17","author":"ED Shah","year":"2019","unstructured":"Shah ED, Saini SD, Chey WD. Value-based pricing for Rifaximin increases access of patients with irritable bowel syndrome with diarrhea to therapy. Clin Gastroenterol Hepatol. 2019;17:2687\u20132695.e11.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6544_CR8","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1053\/j.gastro.2018.08.021","volume":"155","author":"CJ Black","year":"2018","unstructured":"Black CJ, Burr NE, Quigley EMM, et al. Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: systematic review and network meta-analysis. Gastroenterology. 2018;155:1753\u20131763.","journal-title":"Gastroenterology"},{"key":"6544_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","volume":"157","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon R, Lau JT, Yuan Y, et al. Gut microbiota in patients with irritable bowel syndrome\u2014a systematic review. Gastroenterology. 2019;157:97\u2013108.","journal-title":"Gastroenterology"},{"key":"6544_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","volume":"114","author":"AC Ford","year":"2019","unstructured":"Ford AC, Lacy BE, Harris LA, et al. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2019;114:21\u201339.","journal-title":"Am J Gastroenterol"},{"key":"6544_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/00042737-200410000-00008","volume":"16","author":"M Dapoigny","year":"2004","unstructured":"Dapoigny M, Bellanger J, Bonaz B, et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol. 2004;16:995\u20131001.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6544_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1477-7525-10-25","volume":"10","author":"JB McCormick","year":"2012","unstructured":"McCormick JB, Hammer RR, Farrell RM, et al. Experiences of patients with chronic gastrointestinal conditions: in their own words. Health Qual Life Outcomes. 2012;10:25.","journal-title":"Health Qual Life Outcomes"},{"key":"6544_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brat.2016.07.006","volume":"88","author":"GD Gudleski","year":"2017","unstructured":"Gudleski GD, Satchidanand N, Dunlap LJ, et al. Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States. Behav Res Ther. 2017;88:65\u201375.","journal-title":"Behav Res Ther"},{"key":"6544_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/rheumatology\/37.8.862","volume":"37","author":"N Hurst","year":"1998","unstructured":"Hurst N, Ruta D, Kind P. Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis. Rheumatology. 1998;37:862\u2013869.","journal-title":"Rheumatology"},{"key":"6544_CR15","doi-asserted-by":"crossref","first-page":"175628481881832","DOI":"10.1177\/1756284818818326","volume":"12","author":"B Lacy","year":"2019","unstructured":"Lacy B, Ayyagari R, Guerin A, et al. Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome. Therap Adv Gastroenterol. 2019;12:1756284818818326.","journal-title":"Therap Adv Gastroenterol"},{"key":"6544_CR16","first-page":"406","volume":"20","author":"DM Bernard","year":"2014","unstructured":"Bernard DM, Johansson P, Fang Z. Out-of-pocket healthcare expenditure burdens among nonelderly adults with hypertension. Am J Manag Care. 2014;20:406\u2013413.","journal-title":"Am J Manag Care"},{"key":"6544_CR17","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1377\/hlthaff.2015.0571","volume":"34","author":"MK Hamman","year":"2015","unstructured":"Hamman MK, Kapinos KA. Affordable care act provision lowered out-of-pocket cost and increased colonoscopy rates among men in medicare. Health Aff (Millwood). 2015;34:2069\u20132076.","journal-title":"Health Aff (Millwood)"},{"key":"6544_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/2050640615600114","volume":"4","author":"N Vakil","year":"2016","unstructured":"Vakil N, Stelwagon M, Shea EP, et al. Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United Eur Gastroenterol J. 2016;4:413\u2013422.","journal-title":"United Eur Gastroenterol J"},{"key":"6544_CR19","doi-asserted-by":"publisher","first-page":"e13629","DOI":"10.1111\/nmo.13629","volume":"31","author":"Z Weerts","year":"2019","unstructured":"Weerts Z, Vork L, Mujagic Z, et al. Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2019;31:e13629.","journal-title":"Neurogastroenterol Motil"},{"key":"6544_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ajg.2013.410","volume":"109","author":"JM Lackner","year":"2014","unstructured":"Lackner JM, Gudleski GD, Thakur ER, et al. The impact of physical complaints, social environment, and psychological functioning on IBS patients\u2019 health perceptions: looking beyond GI symptom severity. Am J Gastroenterol. 2014;109:224\u2013233.","journal-title":"Am J Gastroenterol"},{"key":"6544_CR21","unstructured":"Ward BW. Barriers to Health Care for Adults With Multiple Chronic Conditions: United States, 2012\u20132015. NCHS Data Brief 2017:1\u20138."},{"key":"6544_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13104-017-2568-y","volume":"10","author":"AM Solheim","year":"2017","unstructured":"Solheim AM, Mygland A, Ljostad U. Quality of multiple sclerosis out-patient health care services with focus on patient reported experiences. BMC Res Notes. 2017;10:250.","journal-title":"BMC Res Notes"},{"key":"6544_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.archger.2017.05.007","volume":"72","author":"JE Kurichi","year":"2017","unstructured":"Kurichi JE, Pezzin L, Streim JE, et al. Perceived barriers to healthcare and receipt of recommended medical care among elderly Medicare beneficiaries. Arch Gerontol Geriatr. 2017;72:45\u201351.","journal-title":"Arch Gerontol Geriatr"},{"key":"6544_CR24","first-page":"2986","volume":"23","author":"ME Flacco","year":"2019","unstructured":"Flacco ME, Manzoli L, De Giorgio R, et al. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis. Eur Rev Med Pharmacol Sci. 2019;23:2986\u20133000.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6544_CR25","first-page":"122","volume":"22","author":"S Hopson","year":"2016","unstructured":"Hopson S, Saverno K, Liu LZ, et al. Impact of out-of-pocket costs on prescription fills among new initiators of biologic therapies for rheumatoid arthritis. J Manag Care Spec Pharm. 2016;22:122\u2013130.","journal-title":"J Manag Care Spec Pharm"},{"key":"6544_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1200\/JCO.2017.74.5091","volume":"36","author":"JA Doshi","year":"2018","unstructured":"Doshi JA, Li P, Huo H, et al. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents. J Clin Oncol. 2018;36:476\u2013482.","journal-title":"J Clin Oncol"},{"key":"6544_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1572-0241.2000.t01-1-01531.x","volume":"95","author":"WL Straus","year":"2000","unstructured":"Straus WL, Eisen GM, Sandler RS, et al. Crohn\u2019s disease: does race matter? The Mid-Atlantic Crohn\u2019s Disease Study Group. Am J Gastroenterol. 2000;95:479\u2013483.","journal-title":"Am J Gastroenterol"},{"key":"6544_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/MLR.0b013e3181d5f9e1","volume":"48","author":"PJ Johnson","year":"2010","unstructured":"Johnson PJ, Carlson KF, Hearst MO. Healthcare disparities for American Indian veterans in the United States: a population-based study. Med Care. 2010;48:563\u2013569.","journal-title":"Med Care"},{"key":"6544_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/HMR.0000000000000150","volume":"43","author":"SR Finkelstein","year":"2018","unstructured":"Finkelstein SR, Liu N, Rosenthal D, et al. When open access might not work: understanding patient attitudes in appointment scheduling. Health Care Manag Rev. 2018;43:348\u2013358.","journal-title":"Health Care Manag Rev"},{"key":"6544_CR30","first-page":"525","volume":"27","author":"DL Greenhouse","year":"1995","unstructured":"Greenhouse DL, Probst JC. After-hours telephone calls in a family practice residency: volume, seriousness, and patient satisfaction. Fam Med. 1995;27:525\u2013530.","journal-title":"Fam Med"},{"key":"6544_CR31","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/MCG.0000000000000906","volume":"52","author":"BM Quigley","year":"2018","unstructured":"Quigley BM, Sova CC, Brenner DM, et al. (Can\u2019t Get No) patient satisfaction: the predictive power of demographic, GI, and psychological factors in IBS patients. J Clin Gastroenterol. 2018;52:614\u2013621.","journal-title":"J Clin Gastroenterol"},{"key":"6544_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1365-2036.2007.03370.x","volume":"26","author":"KA Nyrop","year":"2007","unstructured":"Nyrop KA, Palsson OS, Levy RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther. 2007;26:237\u2013248.","journal-title":"Aliment Pharmacol Ther"},{"key":"6544_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12875-015-0323-9","volume":"16","author":"M Murphy","year":"2015","unstructured":"Murphy M, Hollinghurst S, Turner K, et al. Patient and practitioners\u2019 views on the most important outcomes arising from primary care consultations: a qualitative study. BMC Fam Pract. 2015;16:108.","journal-title":"BMC Fam Pract"},{"key":"6544_CR34","doi-asserted-by":"publisher","first-page":"e654","DOI":"10.3399\/bjgp18X698321","volume":"68","author":"A Sibelli","year":"2018","unstructured":"Sibelli A, Moss-Morris R, Chalder T, et al. Patients\u2019 perspectives on GP interactions after cognitive behavioural therapy for refractory IBS: a qualitative study in UK primary and secondary care. Br J Gen Pract. 2018;68:e654\u2013e662.","journal-title":"Br J Gen Pract"},{"key":"6544_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10620-009-0855-8","volume":"55","author":"A Halpert","year":"2010","unstructured":"Halpert A, Dalton CB, Palsson O, et al. Irritable bowel syndrome patients\u2019 ideal expectations and recent experiences with healthcare providers: a national survey. Dig Dis Sci. 2010;55:375\u2013383. https:\/\/doi.org\/10.1007\/s10620-009-0855-8.","journal-title":"Dig Dis Sci"},{"key":"6544_CR36","first-page":"289","volume":"7","author":"JL Buono","year":"2014","unstructured":"Buono JL, Tourkodimitris S, Sarocco P, et al. Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials. Am Health Drug Benefits. 2014;7:289\u2013297.","journal-title":"Am Health Drug Benefits"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06544-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06544-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06544-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:28:04Z","timestamp":1629419284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06544-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["6544"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06544-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study only uses de-identified data that are in the public domain. No consent or IRB approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent and study approval"}}]}}